Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study: Racial disparities in gyn-onc trial enrollment persist

Key clinical point: Enrollment of black patients in phase 1 gynecologic oncology clinical trials is 1,750%-5,300% lower than expected, depending on cancer site studied.

Major finding: The enrollment ratio in ovarian cancer studies was 0.04:1 for black and white patients, respectively, while the ratios for endometrial and cervical cancer were 0.004:1 and 0.025:1, respectively.

Study details: A review of 357 studies involving 9,492 patients.

Disclosures: Mr. Awad reported having no disclosures.

Citation:

Awad E et al. SGO 2019, Abstract 22.